VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Anheuser-Busch InBev SA/NV vs Amgen Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Anheuser-Busch InBev SA/NV
ABI · Euronext Brussels
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Anheuser-Busch InBev SA/NV's moat claims, evidence, and risks.
View ABI analysisAmgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Anheuser-Busch InBev SA/NV leads (75 / 100 vs 70 / 100 for Amgen Inc.).
- Segment focus: Anheuser-Busch InBev SA/NV has 6 segments (28.6% in Middle Americas); Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines).
- Primary market structure: Duopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Anheuser-Busch InBev SA/NV has 5 moat types across 3 domains; Amgen Inc. has 5 across 3.
Primary market context
Anheuser-Busch InBev SA/NV
Middle Americas
Beer and malt-based beverages (plus growing no-alcohol and Beyond Beer)
Mexico, Central America, and Caribbean (AB InBev reporting segment)
Retailers and on-premise outlets
Brewer / brand owner + route-to-market operator
28.6%
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Side-by-side metrics
Moat coverage
Shared moat types
Anheuser-Busch InBev SA/NV strengths
Amgen Inc. strengths
Segment mix
Anheuser-Busch InBev SA/NV segments
Full profile >North America
Oligopoly
Middle Americas
Duopoly
South America
Oligopoly
EMEA
Oligopoly
Asia Pacific
Competitive
Global Export & Holding Companies
Competitive
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.